Investigating PI3Kinase and K-ras pathway interactions in mouse model of colorectal cancer

被引：0
|
作者：
Meniel, V. [1 ]
Martin-Berenjeno, I. [2 ]
Vanhaesebroeck, B. [2 ]
Clarke, A. R. [1 ]
机构：
[1] Cardiff Univ, European Canc Stem Cell Res Inst, Cardiff CF10 3AX, S Glam, Wales
[2] UCL, UCL Canc Inst, London, England
来源：
EUROPEAN JOURNAL OF CANCER | 2014年 / 50卷
关键词：
D O I：
10.1016/S0959-8049(14)50501-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
566
引用
收藏
页码：S136 / S136
页数：1
相关论文
共 50 条
  • [1] K-RAS hyperexchange mutants in colorectal cancer
    Haigis, Kevin
    MOLECULAR CANCER RESEARCH, 2023, 21 (05)
  • [2] Evaluation of K-RAS gene in colorectal cancer
    Okulczyk, B
    Piotrowski, Z
    Kovalchuk, O
    Niklinski, J
    Chyczewski, L
    FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2003, 41 (02) : 97 - 100
  • [3] K-ras Mutations and Cetuximab in Colorectal Cancer
    Albitar, Maher
    Yeh, Chenhsiung
    Ma, Wanlong
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (08): : 834 - 834
  • [4] Therapeutic modulation of k-ras signaling in colorectal cancer
    Krens, Lisanne L.
    Baas, Jara M.
    Gelderblom, Hans
    Guchelaar, Henk-Jan
    DRUG DISCOVERY TODAY, 2010, 15 (13-14) : 502 - 516
  • [5] K-ras Mutations in the Plasma of Colorectal Cancer Patients
    Shen, Yong-qi
    Ye, Yun-bin
    Zheng, Xiong-wei
    Li, Chao
    Chen, Qiang
    LABMEDICINE, 2010, 41 (03): : 156 - 158
  • [6] K-RAS gene mutations and susceptibility to colorectal cancer
    Prasad, S. S.
    Sekaran, A.
    Rao, G. V.
    Rebala, P.
    Tandan, M.
    Kaitha, A.
    Reddy, D. N.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2011, 26 : 221 - 222
  • [7] K-ras mutation in colorectal cancer treated with cetuximab
    Barbareschi, M.
    Girlando, S.
    Soini, B.
    Cuorvo, L.
    Fasanella, S.
    Cantaloni, C.
    Piccolo, A.
    Prosdocimi, F.
    Galligioni, E.
    Dalla Palma, P.
    VIRCHOWS ARCHIV, 2009, 455 : 396 - 396
  • [8] K-ras gene mutations in normal colorectal tissues from K-ras mutation-positive colorectal cancer patients
    Zhu, D
    Keohavong, P
    Finkelstein, SD
    Swalsky, P
    Bakker, A
    Weissfeld, J
    Srivastava, S
    Whiteside, TL
    CANCER RESEARCH, 1997, 57 (12) : 2485 - 2492
  • [9] IPMK is Indispensable for Activation of AKT: Redefining PI3kinase pathway
    Guha, Prasun
    FASEB JOURNAL, 2020, 34
  • [10] Strategies targeting the PI3k/AKT pathway: rapamycin and its derivatives as lead compounds for downstream inhibition of the PI3kinase pathway
    Raymond, E.
    EJC SUPPLEMENTS, 2004, 2 (03): : 63 - 63
12345